Market Update: Is There An Oversold Rally Amid The Indexes' Descent?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Access Update- #19 After digging around all weekend and most of today, our take is that we agree with Cytori Therapeutics’ (Nasdaq; CYTX) stance that the recent loss in a patent dispute should not impact the company’s business. Here’s why: The judge in the case said the patent covered isolated stem cells that were free…
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Access Update- #18 In case you’re wondering why Cytori Therapeutics (Nasdaq: CYTX) is down on heavy volume today, Artecel – the company that won the patent suit referred to in Update #17 – issued a press release last night. This subhead in the release is what likely spooked investors: “Cytori and UC lose rights to…
Access Update- #17 It’s been an interesting week or so for Cytori Therapeutics (Nasdaq: CYTX). It started off with the University of California, losing a court decision over who owns the rights to a stem cell patent. Cytori licenses the patent from UC. However, Cytori is not using and had no current plans to use…
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Email – #429 Every once in a while, an opportunity arises to really accelerate your profits at a very low price. Of course, every pick we make is at a very low price compared to what the underlying shares cost us. That provides us with some measure of security when things don’t go our way…
Email – #430 Just to be clear, here are the instructions for the trade: Buy the USAir (NYSE: LCC) January 2010 $10 call (LUL-AB) currently trading at $0.85. Do not pay more than $0.85 – remember this is a speculation – do not chase the prices.
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?
Email – #428 It never ceases to amaze me when the market begins to feed on itself. You wake up one day and it seems that the entire market is focusing on one stock, one sector and regardless of what logic dictates, it’s the immediate short term that matters most to traders and investors. Regardless…
Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?